FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for LOTREL (amlodipine besylate and benazepril hydrochloride) by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• LOTREL (amlodipine besylate and benazepril hydrochloride)

Snippet

SUPPL AP for LOTREL (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE)